SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950133-98-002127
Filing Date
1998-05-28
Accepted
1998-05-28 00:00:00
Documents
2
Group Members
BB BIOTECH AGBIOTECH TARGET S.A.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 13901
2 JOINT FILING AGREEMENT EX-4 1912
  Complete submission text file 0000950133-98-002127.txt   17969
Mailing Address 35 W WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 35 W WATKINS MILL RD GAITHERSBURG MD 20878 3014170770
MEDIMMUNE INC /DE (Subject) CIK: 0000873591 (see all company filings)

IRS No.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42057 | Film No.: 98632481
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000